Drug Database
Back to search

Poland· PL-100375323

Betaxomyl

A betaxolol product containing betaxololi hydrochloridum, registered in Poland by Viatris Ltd. The same ATC class is registered in 8 of our 19 countries.

ATC C07AB05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBetaxomylATCC07AB05REGISTER NO.PL-100375323PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about betaxololi hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Betaxolol is registered in 8 of 19 countries.

Countries holding a registration under ATC C07AB05 (betaxolol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search betaxolol products by name

Betaxolol · ATC C07AB05

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Germany
  • Japan
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Betaxololi hydrochloridum
Manufacturer
Viatris Ltd
Country
Poland (PL)
ATC code
C07AB05
ATC class
Betaxolol
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991304195

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

223 interactions on record for betaxolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check betaxolol against other medicinesHow interaction checks work

Betaxolol · interactions on record

223 records

  • 11 severe
  • 184 moderate
  • 20 minor
  • 8 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Betaxolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betaxolol products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Betoptic S
  • Belgium · Betoptic, Betoptic S
  • Bulgaria · Бетак, Бетоптик S
  • Cyprus · Betac
  • Czechia · Betamed, Betaxolol Medreg
  • Germany · Betoptima, Kerlone
  • Denmark · Betoptic S
  • Estonia · Betoptic S
  • Spain · Betoptic
  • Finland · Betoptic, Betoptic S
  • France · Betaxolol Biogaran, Betaxolol Eg
  • United Kingdom (Northern Ireland) · Betoptic
  • Greece · Betoptic, Betoptic S
  • Croatia · Betoptic
  • Hungary · Betoptic, Lokren
  • Italy · Betoptic, Kerlon
  • Lithuania · Betac, Betaxolol Pmcs
  • Luxembourg · Betoptic, Betoptic S
  • Latvia · Betac, Betaxolol Pmcs
  • Netherlands · Betoptic S
  • Norway · Betoptic, Betoptic S
  • Portugal · Bertocil, Betoptic
  • Romania · Betaxolol Gemax Pharma, Betoptic S
  • Sweden · Betoptic, Betoptic S
  • Slovenia · Betoptic, Betoptic S
  • Slovakia · Betac, Betaxolol Medreg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff79b829-963a-4c08-9efb-d428f2e46e7b
GET /v1/drugs/ff79b829-963a-4c08-9efb-d428f2e46e7b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909991304195 ¦ Rp ¦ 118876\n28 tabl.",
  "substance": "Betaxololi hydrochloridum 20 mg",
  "common_name": "Betaxololi hydrochloridum",
  "pl_product_id": "100375323",
  "pozwolenie_nr": "23585",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about betaxolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console